CVN's Top Trials of 2022: Honorable Mentions!
Mar 9, 2023
Check out the top trials CVN covered in 2022 that ended in settlements or mistrials.
Mar 2, 2023
Sargon hearing in bellwether Zantac litigation
View Proceeding
Feb 23, 2023
A South Carolina state court jury returned a $29.14 million verdict in a lawsuit filed by a woman claiming she developed fatal cancer from exposure to asbestos in cosmetic talc products, and the full trial was recorded gavel-to-gavel by Courtroom ...
View Proceeding
Feb 23, 2023
Jurors Friday levied a $5 million verdict against Philip Morris in finding the company and its Marlboro cigarettes responsible for the laryngeal cancer a Massachusetts man developed.
Read More
Jury Awards $6M in Trial Against RJR Over Florida Woman's COPD Death
Feb 1, 2023
Jurors last week awarded $6 million to the family of a Florida woman after finding R.J. Reynolds responsible for her respiratory disease-related death.
Jan 30, 2023
Jury trial in opioid crisis-related lawsuit.
View Proceeding
Jan 12, 2023
Our picks for the Top 10 most impressive defense verdicts CVN covered in 2022!
Read More
Jan 5, 2023
Our picks for the Top 10 most impressive plaintiff verdicts CVN covered in 2022!
Read More
Washington State Jury Awards $82M In Latest Monsanto PCB ‘Forever Chemical’ Trial
Dec 21, 2022
A Washington state jury returned a verdict of $82 million on Tuesday at the latest in a series of trials involving exposure to dangerous and long-lasting chemicals at a local school.
Dec 19, 2022
Plaintiff contends a defect in a Ford truck's roof caused the deaths of two people.
View Proceeding
Dec 8, 2022
In this tobacco liability case, Elsa Chacon, claims defendant tobacco manufacturers concealed the dangers of cigarettes, leading to the nicotine addiction and smoking-related disease of Robiel Chacon.
View Proceeding
Dec 2, 2022
Attorneys Monday debated what responsibility, if any, R.J. Reynolds bears for the deadly throat cancer a New Mexico man developed after decades of smoking, as trial opened against the tobacco giant.
Read More
